Bacillus subtilis produces an anionic bacteriocin called subtilosin A that possesses antibacterial activity against certain gram-positive bacteria. In this study, we uncovered a hemolytic mutant of B. subtilis that produces an altered form of subtilosin A. The mutant bacteriocin, named subtilosin A1, has a replacement of threonine at position 6 with isoleucine. In addition to the hemolytic activity, subtilosin A1 was found to exhibit enhanced antimicrobial activity against specific bacterial strains. The B. subtilis albB mutant that does not produce a putative immunity peptide was more sensitive to both subtilosin A and subtilosin A1. A spontaneous suppressor mutation of albB that restored resistance to subtilosin A and subtilosin A1 was obtained. The sbr (subtilosin resistance) mutation conferring the resistance is not linked to the sboA-alb locus. The sbr mutation does not increase the resistance of B. subtilis to other cell envelope-targeted antimicrobial agents, indicating that the mutation specifically confers the resistance to subtilosins. The findings suggest possible bioengineering approaches for obtaining anionic bacteriocins with enhanced and/or altered bactericidal activity. Furthermore, future identification of the subtilosin-resistant mutation could provide insights into the mechanism of subtilosin A activity.Bacteria produce a variety of secondary metabolites, such as antibiotics and bacteriocins. Bacteriocins are proteinaceous antimicrobial substances that are often distinguished from traditional antibiotics by their narrow range of activity against closely related bacteria. However, bacteriocins produced by gram-positive bacteria show a relatively broader spectrum than those from gram-negative bacteria (reviewed in references 14 and 22). Various gram-positive bacteria produce small bacteriocins that are ribosomally synthesized peptides but that are often heavily modified during posttranslational processing. The target of these bacteriocins is primarily the cytoplasmic membrane, where they create pores through which ions can pass, leading eventually to cell death.Subtilosin A is a 35-amino-acid bacteriocin originally isolated from Bacillus subtilis by Babasaki et al. (2) but was also found in Bacillus atrophaeus (26) and Bacillus amyloliquefaciens isolated from a dairy product (29). It is a unique macrocyclic bacteriocin in part due to its having an anionic nature unlike many other membrane-targeting cationic bacteriocins. Subtilosin A is formed from its precursor by proteolytic cleavage of the N-terminal leader peptide and cyclization through covalent linkage between the N-terminal asparagine and the C-terminal glycine. Structure analysis of subtilosin A by 1 H nuclear magnetic resonance (NMR) spectrometry suggested the formation of thioether bonds between Cys4/Phe31, Cys7/ Thr28, and Cys13/Phe22, but the actual sites of connection were unknown (15). Subsequent isotopic labeling and multidimensional NMR analysis demonstrated unprecedented crosslinking between sulfurs of the cysteines and the ␣ ca...